Transthyretin Familial Amyloid Polyneuropathy
📧 Sign up to get email alerts when something new happens for Transthyretin Familial Amyloid Polyneuropathy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-02-03Clinical Trial Update: Vyndaqel Drug Use Investigation (Regulatory Post Marketing Commitment Plan)
Pfizer's post-marketing commitment study evaluating real-world use of Vyndaqel (tafamidis) in patients with transthyretin familial amyloid p…
-
CLINICAL_TRIALS trial_result · 2015-09-09Clinical Trial Update: The Effect Of Tafamidis For The Transthyretin Amyloid Polyneuropathy Patients With V30M Or Non-V30M Transthyretin [Phase 3]
Phase 3 trial evaluating tafamidis in patients with transthyretin familial amyloid polyneuropathy completed, with results posted in 2015.